{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:12:52Z","timestamp":1789791172903,"version":"4.0.1"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea grant funded by the Korea government","award":["2019R1A2C1003218"],"award-info":[{"award-number":["2019R1A2C1003218"]}]},{"name":"the BK21 FOUR Project","award":["."],"award-info":[{"award-number":["."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Diabetes induces bone deterioration, which leads to increased risk of fracture, osteopenia, and osteoporosis. Thus, diabetes-associated bone fragility has been recognized as a diabetic complication. However, the pathophysiological effects of hyperglycemia on bone turnover remain unclear. Literature evidence demonstrates that anti-diabetic medications increase the risk of fractures in individuals with type 2 diabetes. Scopoletin is a naturally occurring hydroxycoumarin potentially exhibiting anti-inflammatory and antioxidant activities and ameliorating insulin resistance as an anti-diabetic agent. However, little is known regarding the effects of scopoletin on the impairment of bone remodeling that is caused by diabetes. The aim of this study was to identify that scopoletin was capable of inhibiting the impairment of bone remodeling and turnover in a mouse model of type 2 diabetes. Submicromolar scopoletin accelerated the formation TRAP-positive multinucleated osteoclasts (40.0 vs. 105.1%) and actin ring structures impaired by 33 mM glucose. Further, 1\u201320 \u03bcM scopoletin enhanced bone resorption and the induction of matrix-degrading enzymes in diabetic osteoclasts. The oral administration of 10 mg\/kg scopoletin elevated serum RANKL\/OPG ratio and osteocalcin level reduced in db\/db mice along with an increase in BMD by ~6\u201314%; however, it was not effective in lowering blood glucose and hemoglobin glycation. In addition, the supplementation of scopoletin elevated the formation of trabecular bones and collagen fibers in femoral epiphysis and metaphysis with a thicker epiphyseal plate and cortical bones. Furthermore, 1\u201320 \u03bcM scopoletin enhanced ALP activity (4.39 vs. 7.02 nmol p-nitrophenyl phosphate\/min\/mg protein) and deposits of mineralized bone nodules in cultured osteoblasts reduced by 33 mM glucose. The treatment of diabetic osteoblasts with scopoletin stimulated the cellular induction of BMP-2 and osteopontin and Runx2 transcription. Accordingly, the administration of scopoletin protected mice from type 2 diabetes-associated bone loss through boosting bone remodeling via the robust induction of bone turnover markers of both osteoclasts and osteoblasts. These findings suggest that scopoletin could be a potential osteoprotective agent for the treatment of diabetes-associated bone loss and fractures.<\/jats:p>","DOI":"10.3390\/biomedicines9060648","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:25:43Z","timestamp":1623072343000},"page":"648","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes"],"prefix":"10.3390","volume":"9","author":[{"given":"Eun-Jung","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Kyung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeongjoo","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Il","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Yeon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-9914","authenticated-orcid":false,"given":"Kyungho","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2039-7968","authenticated-orcid":false,"given":"Young-Hee","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition and Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/dmrr.1197","article-title":"Diabetes and bone health: The relationship between diabetes and osteoporosis-associated fractures","volume":"27","author":"Kurra","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11914-007-0025-x","article-title":"Diabetes, fracture, and bone fragility","volume":"5","author":"Schwartz","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bone.2015.07.027","article-title":"Determinants of bone strength and quality in diabetes mellitus in humans","volume":"82","author":"Farr","year":"2016","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MED.0b013e328331c7eb","article-title":"Diabetes and fractures: An overshadowed association","volume":"16","author":"Khazai","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2010.12.016","article-title":"Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone","volume":"48","author":"Nyman","year":"2011","journal-title":"Bone"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","article-title":"Type 2 diabetes and the skeleton: New insights into sweet bones","volume":"4","author":"Shanbhogue","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4239\/wjd.v10.i8.421","article-title":"Bone health in diabetes and prediabetes","volume":"10","author":"Costantini","year":"2019","journal-title":"World J. Diabetes"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","article-title":"Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues","volume":"289","author":"Thrailkill","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphar.2018.01517","article-title":"Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk","volume":"9","author":"Ye","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Horii, T., Iwasawa, M., Kabeya, Y., Shimizu, J., and Atsuda, K. (2019). Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: A retrospective study. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0413-0"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41598-017-03748-z","article-title":"Insulin use and excess fracture risk in patients with type 2 diabetes: A propensity-matched cohort analysis","volume":"7","author":"Hawley","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_14","first-page":"3957","article-title":"Insulin use and fracture risk in patients with type 2 diabetes: A meta-analysis of 138,690 patients","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_15","first-page":"6969040","article-title":"Sweet bones: The pathogenesis of bone alteration in diabetes","volume":"2016","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11914-016-0332-1","article-title":"Advanced glycation end products, diabetes, and bone strength","volume":"14","author":"Yamamoto","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2174\/138945011798829456","article-title":"Role of advanced glycation end products (AGEs) in osteoporosis in diabetes","volume":"12","author":"Yamagishi","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"ref_18","first-page":"21","article-title":"Diabetes, biochemical markers of bone turnover, diabetes control, and bone","volume":"4","year":"2013","journal-title":"Front. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1210\/jc.2006-0460","article-title":"Type 2 diabetes mellitus in nursing home patients: Effects on bone turnover, bone mass, and fracture risk","volume":"91","author":"Dobnig","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/13880200802367155","article-title":"Anti-inflammatory effects of scopoletin and underlying mechanisms","volume":"46","author":"Ding","year":"2008","journal-title":"Pharmaceut. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-2007-969809","article-title":"Mechanism of the hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera","volume":"49","author":"Ojewole","year":"1983","journal-title":"Planta Med."},{"key":"ref_23","first-page":"501","article-title":"Inhibitory effects of phenolics on xanthine oxidase","volume":"14","author":"Chang","year":"1994","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ptr.1170","article-title":"Antioxidant properties of scopoletin isolated from Sinomonium acutum","volume":"17","author":"Shaw","year":"2003","journal-title":"Phytother. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nut.2016.08.006","article-title":"Noni leaf and black tea enhance bone regeneration in estrogen-deficient rats","volume":"33","author":"Shalan","year":"2017","journal-title":"Nutrition"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-018-3432-7","article-title":"Supplementation of scopoletin improves insulin sensitivity by attenuating the derangements of insulin signaling through AMPK","volume":"453","author":"Kalpana","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/molecules20022786","article-title":"Scopoletin protects against methylglyoxal-induced hyperglycemia and insulin resistance mediated by suppression of advanced glycation endproducts (AGEs) generation and anti-glycation","volume":"20","author":"Chang","year":"2015","journal-title":"Molecules"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lee, E.J., Kang, M.K., Kim, Y.H., Kim, D.Y., Oh, H., Kim, S.I., Oh, S.Y., Na, W., and Kang, Y.H. (2020). Coumarin ameliorates impaired bone turnover by inhibiting the formation of advanced glycation end products in diabetic osteoblasts and osteoclasts. Biomolecules, 10.","DOI":"10.3390\/biom10071052"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","article-title":"The osteoclast and its unique cytoskeleton","volume":"1240","author":"Teitelbaum","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molmed.2014.06.001","article-title":"Osteoclasts: More than bone eaters","volume":"20","author":"Charles","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"41155","DOI":"10.1074\/jbc.M506366200","article-title":"Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-\u03baB ligand","volume":"280","author":"Schneeweis","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.12659\/MSMBR.901142","article-title":"Osteoblast differentiation at a glance","volume":"22","author":"Rutkovskiy","year":"2016","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdsr.2009.10.003","article-title":"Molecular mechanisms of BMP-induced bone formation: Cross-talk between BMP and NF-\u03baB signaling pathways in osteoblastogenesis","volume":"46","author":"Jimi","year":"2010","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4419-1050-9_5","article-title":"Regulation of osteoblast differentiation by Runx2","volume":"658","author":"Komori","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jnutbio.2017.07.014","article-title":"Dietary phlorizin enhances osteoblastogenic bone formation through enhancing \u03b2-catenin activity via GSK-3\u03b2 inhibition in a model of senile osteoporosis","volume":"49","author":"Antika","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11684-013-0243-9","article-title":"Impact of diabetes and its treatments on skeletal diseases","volume":"7","author":"Yan","year":"2013","journal-title":"Front. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bone.2018.04.004","article-title":"Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes","volume":"112","author":"Stage","year":"2018","journal-title":"Bone"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.pharep.2017.05.008","article-title":"Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies","volume":"69","author":"Adil","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.biopha.2018.11.032","article-title":"Metformin; an old antidiabetic drug with new potentials in bone disorders","volume":"109","author":"Bahrambeigi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MNH.0b013e3283451901","article-title":"Mouse models of diabetic nephropathy","volume":"20","author":"Alpers","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"Diabetes mellitus, a state of low bone turnover-a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2016.03.009","article-title":"Glycemic control and fracture risk in elderly patients with diabetes","volume":"115","author":"Conway","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jc.2018-01879","article-title":"Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study","volume":"104","author":"Vavanikunnel","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","first-page":"803","article-title":"Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats","volume":"19","author":"Yamaguchi","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jre.12678","article-title":"Oral supplementation with p-coumaric acid protects mice against diabetes-associated spontaneous destruction of periodontal tissue","volume":"54","author":"Bhattarai","year":"2019","journal-title":"J. Periodontal Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/648\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:11:33Z","timestamp":1760163093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biomedicines9060648"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9060648","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}